Lv5
824 积分 2024-02-15 加入
ECD, a novel androgen receptor target promotes prostate cancer tumorigenesis by regulating glycolysis
28天前
已完结
First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trial
28天前
已完结
Prevalence of germline pathogenic variants in 779 patients with metastatic prostate cancer
28天前
已完结
Factors Affecting Quality Control (QC) Failure Rates in Somatic Breast Cancer (BRCA) Gene Testing in Castrate Resistant Prostate Cancer: Experiences From an Australian Cancer Care Centre
28天前
已完结
Treatment Patterns and Outcomes in Lymph-Node-Positive (pN1) Prostate Cancer: A National Cancer Database Study
28天前
已完结
Maintenance avelumab in metastatic urothelial carcinoma: do tumour site and previous surgery matter?
28天前
已完结
Oncologic and renal function outcomes of segmental ureterectomy vs. radical nephroureterectomy in upper tract urothelial carcinoma: A systematic review and meta-analysis
28天前
已完结
Effectiveness and Safety of Cabozantinib Treatment in Patients with Advanced Renal Cell Carcinoma in Spanish and Portuguese Real-world Practice: The SOGUG-SPRWEC Study
28天前
已完结
Sintilimab Plus Axitinib for Advanced Fumarate Hydratase-Deficient Renal Cell Carcinoma: A Phase 2 Nonrandomized Clinical Trial
28天前
已完结
皖公网安备34019202002308
